Sterling Capital Management’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.5K Buy
1,969
+1,825
+1,267% +$20.7K ﹤0.01% 2191
2026
Q2
$1.48K Buy
+144
New +$1.34K ﹤0.01% 3059

Other funds holding IMMX

Sterling Capital Management's IMMX Position: Q3 2026 in Review

Sterling Capital Management increased its Immix Biopharma (IMMX) stake by 1,267% in Q3 2026, buying an estimated $20.7K and bringing the position to 1,969 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2191.

Sterling Capital Management first reported a position in IMMX in Q2 2026 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Sterling Capital Management held 1,969 shares of Immix Biopharma worth $20.5K as of Q3 2026.
  • Sterling Capital Management bought 1,825 Immix Biopharma shares in Q3 2026, an estimated $20.7K.
  • Immix Biopharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2191 holding.
  • Sterling Capital Management first reported a position in Immix Biopharma in Q2 2026 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.